Expanding role of antibodies in kidney transplantation

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 1

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Transplant. Mar 18, 2025; 15(1): 99220
Published online Mar 18, 2025. doi: 10.5500/wjt.v15.i1.99220

Table 4 Examples of some traditional and emerging therapies in kidney transplantation

Traditional therapies	Plasmapheresis
	Immunoadsorption
	Intravenous immunoglobulin
	Anti-CD20 monoclonal antibody rituximab
	Complement inhibitors: Eculizumab, C1 INH
	Proteasome inhibitors: Bortezomib
Emerging therapies	Carfilzomib
	Tocilizumab
	Clazakizumab
	Daratumumab
	Belimumab
	Imlifidase
	Ofatumumab
	Obinutuzumab
	Inebilizumab

Citation: Abbas K, Mubarak M. Expanding role of antibodies in kidney transplantation. World J Transplant 2025; 15(1): 99220
URL: https://www.wjgnet.com/2220-3230/full/v15/i1/99220.htm
DOI: https://dx.doi.org/10.5500/wjt.v15.i1.99220

Abbas K, Mubarak M. Expanding role of antibodies in kidney transplantation. World J Transplant 2025; 15(1): 99220 [PMID: 40104192 DOI: 10.5500/wjt.v15.i1.99220]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.